29,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
15 °P sammeln
  • Broschiertes Buch

Overproduction of aldosterone represents a major medical challenge, leading to complications such as hypertension. In this context, the use of 61Cobalt-labeled eplerenone, combined with targeted X-rays, is emerging as a novel approach. This promising method aims to selectively target affected adrenal tissue while minimizing damage to surrounding tissue. Preclinical studies have shown potential efficacy in animal models, with encouraging safety results. However, clinical trials are needed to validate this method in human patients. This approach opens the way to personalized and effective…mehr

Produktbeschreibung
Overproduction of aldosterone represents a major medical challenge, leading to complications such as hypertension. In this context, the use of 61Cobalt-labeled eplerenone, combined with targeted X-rays, is emerging as a novel approach. This promising method aims to selectively target affected adrenal tissue while minimizing damage to surrounding tissue. Preclinical studies have shown potential efficacy in animal models, with encouraging safety results. However, clinical trials are needed to validate this method in human patients. This approach opens the way to personalized and effective treatment options for patients suffering from aldosterone overproduction, representing a significant advance in the field of hypertension management.
Autorenporträt
Investigador independente especializado em química bioinorgânica, o Dr. Mimouni é um perito em XAS. Obteve o seu doutoramento em Química pela Universidade de Paris XII em 1997, depois de ter concluído um Diplôme d'Études Approfondies en Systèmes Bioinorganiques, uma Maîtrise e uma Licence en Chimie, na Universidade de Paris XI em 1993/92/91,